Related Experiment Video

Updated: Feb 24, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

4.1K

Making It Personal: Neoantigen Vaccines in Metastatic Melanoma

Matthew D Hellmann1, Alexandra Snyder2

  • 1Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Ave., New York, NY 10028, USA.

Immunity
|August 17, 2017
PubMed

Insights

Neoantigen vaccines, derived from cancer mutations, show promise in treating advanced melanoma. Early studies demonstrate immune system recognition and positive safety and efficacy in phase I trials.

Area of Science:

  • Oncology
  • Immunology
  • Vaccine Development

Background:

  • Somatic mutations in cancer generate neoantigens, which are peptides recognized as foreign by the immune system.
  • Advanced melanoma (Stage III/IV) presents significant therapeutic challenges.

Purpose of the Study:

  • To evaluate the immunogenicity, safety, and efficacy of neoantigen vaccines in patients with advanced melanoma.
  • To assess the clinical potential of personalized cancer vaccines.

Main Methods:

  • Two independent phase I clinical studies were conducted.
  • Patients with stage III or IV melanoma received neoantigen vaccines.
  • Immunogenicity was assessed by measuring immune responses to neoantigens.

Main Results:

  • Neoantigen vaccines demonstrated immunogenicity in melanoma patients.
  • Intriguing clinical safety data were observed in phase I trials.
  • Promising efficacy signals were reported, warranting further investigation.

Conclusions:

  • Neoantigen vaccines represent a potential therapeutic strategy for advanced melanoma.
  • These findings support the continued development of personalized cancer vaccines.
  • Further clinical trials are needed to confirm safety and efficacy.

More Related Videos

A 3D Organotypic Melanoma Spheroid Skin Model08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

16.7K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.9K

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K